跳转至内容
Merck

S3944

Sigma-Aldrich

SEW2871

≥98% (HPLC), solid

别名:

5- [4-苯基-5-(三氟甲基)-2-噻吩基]-3- [3-(三氟甲基)苯基]-1,2,4-恶二唑

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C20H10F6N2OS
分子量:
440.36
MDL编号:
UNSPSC代码:
12352211
PubChem化学物质编号:
NACRES:
NA.77

方案

≥98% (HPLC)

表单

solid

储存条件

protect from light

颜色

white

mp

94.5-95.3 °C

溶解性

DMSO: ≥10 mg/mL
H2O: insoluble

储存温度

2-8°C

SMILES字符串

FC(F)(F)c1cccc(c1)-c2noc(n2)-c3cc(-c4ccccc4)c(s3)C(F)(F)F

InChI

1S/C20H10F6N2OS/c21-19(22,23)13-8-4-7-12(9-13)17-27-18(29-28-17)15-10-14(11-5-2-1-3-6-11)16(30-15)20(24,25)26/h1-10H

InChI key

OYMNPJXKQVTQTR-UHFFFAOYSA-N

应用

SEW2871可用于模拟HUVEC中的1-磷酸鞘氨醇的作用,以研究长穿透素3所产生的先天免疫力。
SEW2871已被用作鞘氨醇-1磷酸酯(S1P)受体激动剂,用于测定重构血浆载脂蛋白(ApoM) /S1P对小鼠血管通透性的作用。

生化/生理作用

SEW2871是1-磷酸鞘氨醇受体的选择性激动剂。其会通过显著延长室性心动过速和室颤的持续时间,加剧再灌注性心律失常。 SEW2871可通过影响淋巴细胞归巢和细胞迁移来调节炎症反应。 通过抑制促炎分子,SEW2871可减少因缺血引起的急性肾衰竭。
新型选择性人鞘氨醇-1-磷酸亚型1(S1P1)受体激动剂。

特点和优势

该化合物在受体分类和信号转导手册中 溶血磷脂受体 页面中进行了详细介绍。想要浏览手册的其他页面, 请单击此处

包装

光敏。

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

个人防护装备

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 1

1 of 1

Yang-Hee Kim et al.
Journal of biomedical materials research. Part A, 104(4), 942-956 (2015-12-26)
In this study, the wound closure of mouse skin defects was examined in terms of recruitment of mesenchymal stem cells (MSC) and macrophages. For the cells recruitment, stromal derived factor-1 (SDF-1) of a MSC recruitment agent and sphingosine-1 phosphate agonist
Jasmin Fettel et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(2), 1711-1726 (2018-09-07)
Sphingosine-1-phosphate (S1P) is involved in the regulation of important cellular processes, including immune-cell trafficking and proliferation. Altered S1P signaling is strongly associated with inflammation, cancer progression, and atherosclerosis; however, the mechanisms underlying its pathophysiologic effects are only partially understood. This
Laura J Sim-Selley et al.
The Journal of pharmacology and experimental therapeutics, 366(3), 509-518 (2018-06-28)
The immunomodulatory prodrug 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol (FTY720), which acts as an agonist for sphingosine-1-phosphate (S1P) receptors (S1PR) when phosphorylated, is proposed as a novel pain therapeutic. In this study, we assessed FTY720-mediated antinociception in the radiant heat tail-flick test and in the
Yayoi T Tsukada et al.
Journal of cardiovascular pharmacology, 50(6), 660-669 (2007-12-20)
Sphingosine-1-phosphate (S1P) has been considered to play an important role in ischemia/reperfusion (I/R) injury. We used SEW2871 (SEW), a novel receptor-selective agonist for S1P1, to elucidate the role of S1P1 in myocardial I/R. Isolated perfused rat hearts exposed to S1P
Frdoos Al Fadel et al.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 40(6), 1637-1645 (2016-12-23)
Ectopic lipid accumulation in hepatocytes has been identified as a risk factor for the progression of liver fibrosis and is strongly associated with obesity. In particular, the saturated fatty acid palmitate is involved in initiation of liver fibrosis via formation

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持